You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 88 No. 6, June 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Critical Evaluation of Vena Cava Plication

Prevention of Pulmonary Embolism

JOHN J. BERGAN, MD; HARRY A. KAUPP, MD; OTTO H. TRIPPEL, MD

AMA Arch Surg. 1964;88(6):1016-1020.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Appearances are deceptive

Aesop: "The Fable of the Wolf in Sheep's Clothing"

A multiplicity of medical and surgical techniques are advocated today in the prevention of pulmonary embolization. The existence of many when one would suffice is evidence of need for a better method of preventing this lethal condition. Unfortunately, the frequency of pulmonary embolus has not decreased during the past 50 years despite increased interest in this condition, improved diagnostic methods, and apparently improved methods of therapy.6,11

Among the several therapeutic regimens advocated in treatment of thromboembolism, anticoagulant drugs have been most widely accepted. The use of adequate anticoagulation is effective in reducing the morbidity and the mortality of major vein thrombosis and pulmonary embolization.8 Both the number of recurrent emboli and the percentage of fatalities attributable to them are decreased.4 In this regard, heparin has appeared to be superior to the prothrombin depressants.12 . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

From the departments of surgery, Veterans Administration Research Hospital, The Chicago Wesley Memorial Hospital, and the Northwestern University School of Medicine.


Footnotes

Submitted for publication Jan 17, 1964.

Aided by a grant from the Chicago Heart Association and the Wesley Vascular Research Fund.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.